![Taro Pharmaceutical Industries Ltd. Logo](/news-release/logo/214827/0/214827.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A32&size=2)
Taro Appoints New Chief Financial Officer
10 avr. 2008 07h00 HE
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., April 10, 2008 (PRIME NEWSWIRE) -- Taro Pharmaceutical Industries Ltd. ("Taro," the "Company") (Pink Sheets:TAROF) announced today that Ron Kolker, C.P.A., has been appointed to the...
![Taro Pharmaceutical Industries Ltd. Logo](/news-release/logo/214827/0/214827.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A32&size=2)
Taro Receives Tentative FDA Approval for Lamotrigine Tablets ANDA
03 avr. 2008 07h00 HE
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., April 3, 2008 (PRIME NEWSWIRE) -- Taro Pharmaceutical Industries Ltd. ("Taro," the "Company,") (Pink Sheets:TAROF) reported today that it has received tentative approval from the U.S....
![Taro Pharmaceutical Industries Ltd. Logo](/news-release/logo/214827/0/214827.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A32&size=2)
Taro Receives FDA Approval for Ondansetron Hydrochloride Injection USP, 2 mg/ml ANDA
25 mars 2008 07h00 HE
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., March 25, 2008 (PRIME NEWSWIRE) -- Taro Pharmaceutical Industries Ltd. ("Taro," the "Company") (Pink Sheets:TAROF) reported today that it has received approval from the U.S. Food and...
![Taro Pharmaceutical Industries Ltd. Logo](/news-release/logo/214827/0/214827.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A32&size=2)
Taro Provides Preliminary 2007 Full Year Results
19 févr. 2008 07h00 HE
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., Feb. 19, 2008 (PRIME NEWSWIRE) -- Taro Pharmaceutical Industries Ltd. ("Taro," the "Company,") (Pink Sheets:TAROF) today provided information for the year ended December 31,...
![Taro Pharmaceutical Industries Ltd. Logo](/news-release/logo/214827/0/214827.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A32&size=2)
Taro Shares to be Delisted From Nasdaq
12 déc. 2006 14h31 HE
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., Dec. 12, 2006 (PRIME NEWSWIRE) -- Taro Pharmaceutical Industries Ltd. ("Taro," the "Company") (Nasdaq:TARO) reported today that it has received notice that the Company's ordinary...
![Taro Pharmaceutical Industries Ltd. Logo](/news-release/logo/214827/0/214827.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A32&size=2)
Taro Receives ANDA Approval For Meloxicam Tablets, 7.5 mg and 15 mg, Generic Equivalent to Mobic
08 nov. 2006 16h53 HE
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., Nov. 8, 2006 (PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. ("Taro," the "Company,") (Nasdaq:TARO) reported today that it has received approval from the U.S. Food and Drug...
![Taro Pharmaceutical Industries Ltd. Logo](/news-release/logo/214827/0/214827.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A32&size=2)
Taro Receives Extension of Time to File 2005 Form 20-F From Nasdaq Panel
13 sept. 2006 07h00 HE
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., Sept. 13, 2006 (PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. ("Taro" or the "Company") (Nasdaq:TARO) today announced that the Nasdaq Listing Qualifications Panel (the "Panel")...
![Taro Pharmaceutical Industries Ltd. Logo](/news-release/logo/214827/0/214827.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A32&size=2)
Taro Receives ANDA Approval For Extended Phenytoin Sodium Capsules, USP 100mg
06 sept. 2006 07h00 HE
|
Taro Pharmaceutical Industries Ltd.
Extended Release Capsules are Generic Equivalent to Pfizer's
Dilantin(R) Kapseals(R)
Taro's Irish Affiliate Also Received its First ANDA Approvals
...
![Taro Pharmaceutical Industries Ltd. Logo](/news-release/logo/214827/0/214827.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A32&size=2)
Taro Receives Approval For Metronidazole Topical Gel USP, 0.75 Percent ANDA
18 juil. 2006 14h28 HE
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., July 18, 2006 (PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. (Nasdaq:TARO) reported today that it has received approval from the U.S. Food and Drug Administration for its...
![Taro Pharmaceutical Industries Ltd. Logo](/news-release/logo/214827/0/214827.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A32&size=2)
Taro Receives Tentative ANDA Approvals For Carvedilol Tablets and Ondansetron HCL Tablets
24 avr. 2006 07h00 HE
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., April 24, 2006 (PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. and its affiliates and subsidiaries (Nasdaq:TARO) reported today that it has received tentative approval from the...